Aclarion, Inc. Files 2024 10-K

Ticker: ACONW · Form: 10-K · Filed: Apr 9, 2025 · CIK: 1635077

Aclarion, INC. 10-K Filing Summary
FieldDetail
CompanyAclarion, INC. (ACONW)
Form Type10-K
Filed DateApr 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, healthcare

TL;DR

Aclarion's 2024 10-K is in. Check financials for Broomfield-based medical lab.

AI Summary

Aclarion, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on April 9, 2025. The company, formerly known as Nocimed, Inc. until February 26, 2015, is based in Broomfield, Colorado. Aclarion operates in the medical laboratories sector, SIC code 8071.

Why It Matters

This filing provides a comprehensive overview of Aclarion's financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new information presented in the provided snippet.

Key Numbers

Key Players & Entities

FAQ

What was Aclarion, Inc.'s former name and when did the name change occur?

Aclarion, Inc. was formerly known as Nocimed, Inc., and the name change occurred on February 26, 2015.

What is Aclarion, Inc.'s primary business sector and SIC code?

Aclarion, Inc. operates in the SERVICES-MEDICAL LABORATORIES sector, with a Standard Industrial Classification (SIC) code of 8071.

Where is Aclarion, Inc. headquartered?

Aclarion, Inc. is headquartered in Broomfield, Colorado, with its business address at 8181 Arista Place, Suite 100.

On what date was the 2024 10-K filing submitted to the SEC?

The 10-K filing for the fiscal year ending December 31, 2024, was filed on April 9, 2025.

What is Aclarion, Inc.'s SEC file number?

Aclarion, Inc.'s SEC file number is 001-41358.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on April 9, 2025 regarding Aclarion, Inc. (ACONW).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing